BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38565910)

  • 1. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer.
    Fang B; Lu Y; Li X; Wei Y; Ye D; Wei G; Zhu Y
    Prostate Cancer Prostatic Dis; 2024 Apr; ():. PubMed ID: 38565910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
    Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
    Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the tumor microenvironment of B cell lymphoma.
    Ng WL; Ansell SM; Mondello P
    J Exp Clin Cancer Res; 2022 Dec; 41(1):362. PubMed ID: 36578079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
    Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
    Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of the tumor immune microenvironment by metformin.
    Wu Z; Zhang C; Najafi M
    J Cell Commun Signal; 2022 Sep; 16(3):333-348. PubMed ID: 34611852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.
    Gunaydin G
    Front Oncol; 2021; 11():668349. PubMed ID: 34336660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
    Akkız H
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
    Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
    Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.
    Ni Y; Zhou X; Yang J; Shi H; Li H; Zhao X; Ma X
    Front Cell Dev Biol; 2021; 9():637675. PubMed ID: 34095111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer.
    Le TT; Hsieh CL; Lin IH; Chu CY; Do AD; Chen SH; Shigemura K; Kitagawa K; Fujisawa M; Liu MC; Chen KC; Sung SY
    Am J Cancer Res; 2022; 12(1):176-197. PubMed ID: 35141012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer.
    Miyake M; Hori S; Morizawa Y; Tatsumi Y; Nakai Y; Anai S; Torimoto K; Aoki K; Tanaka N; Shimada K; Konishi N; Toritsuka M; Kishimoto T; Rosser CJ; Fujimoto K
    Neoplasia; 2016 Oct; 18(10):636-646. PubMed ID: 27690238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis.
    Bonollo F; Thalmann GN; Kruithof-de Julio M; Karkampouna S
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32668821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the tumor microenvironment (TME) by melatonin.
    Mu Q; Najafi M
    Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.